Navigation Links
Thomson Reuters Launches New Biomarkers Solution
Date:6/17/2008

BIOMARKERcenter is First Comprehensive and Quality Assured Biomarker

Solution Available to the Pharmaceutical Industry

PHILADELPHIA and LONDON, June 17 /PRNewswire-FirstCall/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, announced today the launch of BIOMARKERcenter, a unique comprehensive resource for biomarker intelligence. This new solution will be the first to provide the pharmaceutical industry with a framework for assessing the potential of a biomarker and to be alerted of any changes in their status.

BIOMARKERcenter covers the biomarkers identified in literature, patents, conferences, clinical trial information, and other sources for all major therapeutic areas: oncology, cardiovascular diseases, diabetes, respiratory disorders, autoimmune diseases and neurological disorders. For each therapy area, it includes not only biomarkers with established clinical usage, but also emerging uses for the biomarker. Each record has been manually created by a team of Thomson Reuters experts and provides a unique report on the biomarker using a novel lifecycle model. Other data provided will include the name, classification, biological entities/processes involved, associated drugs, role or utilities, measurement techniques, regulatory status and related diagnostic kits.

Biomarkers are measurable indicators which can be used to define a biological state. Using Biomarkers as part of a pharmaceutical R&D program can increase the success of the project by encouraging innovation, improving efficiency, saving costs and delivering a valuable advantage over competitors.

"BIOMARKERcenter is the first reliable and comprehensive database of biomarkers available to the pharmaceutical and diagnostic industries. It sets a new standard for the presentation and analysis of Biomarker information," said Jon Brett-Harris, EVP Pharmaceutical and Chemicals Markets, Thomson Reuters. "Biomarkers have the capacity to change the way pharmaceutical companies develop drugs and bring them to the market. They allow companies to improve their clinical trials design, and better understand the biology of the diseases they are targeting, and we believe BIOMARKERcenter will become an essential tool for our customers."

This new solution will be available through several delivery methods: a standalone web solution, fully integrated into Prous Science's Integrity(R) platform, or as an XML feed to internal customer databases. The Integrity integration and XML feed are available currently, with the standalone solution to be delivered later in 2008.

For further information about BIOMARKERcenter, please go to: http://scientific.thomsonreuters.com/products/biomarkercenter/

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to http://www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Scientific Begins Expansion of Web of Science
2. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
3. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
4. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
5. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
6. Cardiac Science Launches Anywhere Data Management for HIS and EMR Systems
7. Cardium Launches New AWARE Clinical Study Website
8. WellCentive Launches New Secure Messaging Platform for Its Patient Registry System
9. ChanTest Launches Redesigned Web Site
10. Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
11. SAFC Hitech Launches Metalorganic Bulk Vapor Distribution System for Compound Semiconductor Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... BARBARA, CALIFORNIA (PRWEB) , ... September 18, 2017 ... ... management, technological innovation and business process optimization firm for the life sciences and ... at the ServiceMax Maximize 2017 conference. , What: Digital Transformation in Medical Device ...
(Date:9/14/2017)... , ... September 14, 2017 ... ... the launch of its CliniControl™ (CC) product portfolio, clinically-relevant starting and ancillary ... translation of human Mesenchymal Stem/Stromal Cell (hMSC)-based therapies. The CliniControl product portfolio ...
(Date:9/14/2017)... Massachusetts (PRWEB) , ... September 14, 2017 , ... ... Big Data Management and exploratory analytics solutions, today announced that its Anzo Smart ... , Each year, KMWorld’s list includes technologies and solutions that help organizations succeed ...
(Date:9/12/2017)... ... September 12, 2017 , ... ... ) has announced the release of their latest product LabCODE™, a novel ... requirements. LabCODE™ offers pre-built capabilities for Biobanking, Pharmacokinetics, Pharmacogenetics, Next Generation ...
Breaking Biology Technology:
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
Breaking Biology News(10 mins):